Hi-Tech (HITK) Receives Final FDA Approval for Levofloxacin; Shares on the Move

Hi-Tech (Nasdaq: HITK) just announced that it has received final FDA approval for its Levofloxacin product. The company has said that Levofloxacin is expected to launch by the end of March.

---

Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!

You May Also Be Interested In

• Celldex Therapeutics (CLDX) Announces 'High Response' CDX-011 Trial Data
• Patriot Coal (PCX) shares halted on breaker, bouncing as co. says entered into $625M financing
• Savient Pharma (SVNT) Moves Higher with Volatility; Bumps Up Against Key Resistance Point

Create E-mail Alert Related Categories

FDA, Hot FDA News, Momentum Movers

Add Your Comment

Name

Subject

Body

Verification can't see the text?
click here to refresh the image.
what's this?

Follow StreetInsider.com On Twitter